---
title: "European stocks \"Eleven Arhats\" | SAP, LVMH Group, Astrazeneca, L'Oréal, Novo Nordisk all fell over 1%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226981632.md"
description: "On Monday (February 3), the stock prices of several European companies fell, with ASML Holding down 1.77% to €709.90, Novo Nordisk down 1.25% to 599.70 Danish Krone, SAP down 1.99%, LVMH down 1.9%, and L'Oréal down 1.3%. AstraZeneca, GlaxoSmithKline, and Roche saw declines of no more than 0.6%, while Sanofi, Nestlé, and Novartis experienced slight increases, with gains not exceeding 0.53%"
datetime: "2025-02-03T17:47:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226981632.md)
  - [en](https://longbridge.com/en/news/226981632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226981632.md)
generator: "portal-rs"
---

# European stocks "Eleven Arhats" | SAP, LVMH Group, Astrazeneca, L'Oréal, Novo Nordisk all fell over 1%

On Monday (February 3rd), ASML Holding's stock price in Amsterdam (ASML.NA) closed down 1.77% at €709.90. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed down 1.25% at 599.70 Danish Krone. SAP in Germany closed down 1.99%, LVMH Group fell 1.9%, L'Oréal dropped 1.3%, AstraZeneca, GlaxoSmithKline, and Roche Pharmaceuticals fell by up to 0.6%, while Sanofi, Nestlé, and Novartis closed up by up to 0.53%

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)
- [LVMUY.US](https://longbridge.com/en/quote/LVMUY.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [301015.CN](https://longbridge.com/en/quote/301015.CN.md)
- [NSRGY.US](https://longbridge.com/en/quote/NSRGY.US.md)
- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)
- [SAP.US](https://longbridge.com/en/quote/SAP.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [NSRGF.US](https://longbridge.com/en/quote/NSRGF.US.md)

## Related News & Research

- [Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says](https://longbridge.com/en/news/299621552.md)
- [Un estudio mundial de gran relevancia revela desigualdades críticas en el acceso a la atención dermatológica](https://longbridge.com/en/news/299181972.md)
- [Novo Nordisk's hemophilia drug clears a key hurdle in Europe](https://longbridge.com/en/news/299356317.md)
- [Novo Nordisk A/S - share repurchase programme | NVO Stock News](https://longbridge.com/en/news/299643883.md)
- [Key facts: AstraZeneca (AZN) NICE OK Enhertu; FDA review; China plan](https://longbridge.com/en/news/299411391.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**